Despite this, topical and intraperitoneally injected SCD inhibitors produce unwanted side effects, such as dry eyes, partial eye closure, dry skin, and alopecia [45,65,72,73]. This evidence concerns the gene SCD and Keratoconjunctivitis sicca.